P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA by Hesong Zou, Wei Liu, Dandan Shan, Huimin Liu, Ting Xie, Wenyang Huang, Yi Wang, Shuhua Yi, Yan Xu, Gang An, Weiwei Sui, Tingyu Wang, Lugui Qiu, Dehui Zou

Get full text

Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy by Wei Liu, Yan Xu, Yi Wang, Lugui Qiu, Ting Xie, Xiaojuan Wang, Huimin Liu, Tonghui Ma, Jianxiang Wang, Gang An, Weiwei Sui, Hesong Zou, Chunyang Wang, Chen Qiu, Dandan Shan, Wenyang Huang, Shuhua Yi, Dehui Zou

Get full text

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma by Wei Liu, Yan Xu, Yi Wang, Huijun Wang, Jun Wei, Lugui Qiu, Huimin Liu, Jianxiang Wang, Weiwei Sui, Yin Shi, Hesong Zou, Wenyang Huang, Shuhua Yi, Dehui Zou, Lianting Chen, Rui Lv, Kefei Wang, Wenjie Xiong, Shuhui Deng, Guangxin Peng, Yueshen Ma, Lulu Lv, Wenting Zheng

Get full text